Volume 80, Issue 10, Pages (November 2011)

Slides:



Advertisements
Similar presentations
Volume 84, Issue 6, Pages (December 2013)
Advertisements

Volume 77, Issue 6, Pages (March 2010)
Volume 24, Issue 7, Pages (July 2016)
Volume 88, Issue 5, Pages (November 2015)
Volume 78, Issue 3, Pages (August 2010)
Volume 84, Issue 6, Pages (December 2013)
Volume 76, Issue 1, Pages (July 2009)
Volume 78, Issue 4, Pages (August 2010)
Volume 91, Issue 2, Pages (February 2017)
Cell Physiol Biochem 2017;42:1945– DOI: /
G.-T. Shin, D.R. Kim, J.-E. Lim, H. Yim, H. Kim  Kidney International 
Volume 82, Issue 6, Pages (September 2012)
Volume 81, Issue 9, Pages (May 2012)
Volume 92, Issue 4, Pages (October 2017)
Jianlin Chen, Martin M. Matzuk, Xin J. Zhou, Christopher Y. Lu 
David J. Nikolic-Paterson, Shuang Wang, Hui Yao Lan 
Volume 71, Issue 3, Pages (February 2007)
Volume 57, Issue 4, Pages (April 2000)
Volume 69, Issue 8, Pages (April 2006)
Volume 67, Issue 3, Pages (March 2005)
Volume 84, Issue 2, Pages (August 2013)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 86, Issue 3, Pages (September 2014)
Volume 81, Issue 9, Pages (May 2012)
Volume 80, Issue 11, Pages (December 2011)
Volume 80, Issue 11, Pages (December 2011)
Volume 88, Issue 3, Pages (September 2015)
Mast cells decrease renal fibrosis in unilateral ureteral obstruction
Volume 85, Issue 6, Pages (June 2014)
Paricalcitol attenuates cyclosporine-induced kidney injury in rats
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Volume 81, Issue 3, Pages (February 2012)
Volume 81, Issue 12, Pages (June 2012)
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
Volume 84, Issue 2, Pages (August 2013)
Volume 84, Issue 5, Pages (November 2013)
Volume 81, Issue 5, Pages (March 2012)
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura 
Activation of Erk1/2 and Akt following unilateral ureteral obstruction
Volume 70, Issue 10, Pages (November 2006)
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Volume 86, Issue 4, Pages (October 2014)
Volume 73, Issue 12, Pages (June 2008)
Volume 92, Issue 3, Pages (September 2017)
Volume 63, Issue 4, Pages (April 2003)
Volume 68, Issue 2, Pages (August 2005)
Volume 76, Issue 5, Pages (September 2009)
Genetic deficiency of adiponectin protects against acute kidney injury
Volume 85, Issue 6, Pages (June 2014)
Volume 67, Issue 2, Pages (February 2005)
Volume 85, Issue 2, Pages (January 2014)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 75, Issue 6, Pages (March 2009)
Robert L. Chevalier, Michael S. Forbes, Barbara A. Thornhill 
Volume 78, Issue 7, Pages (October 2010)
Volume 58, Issue 6, Pages (December 2000)
Volume 82, Issue 2, Pages (July 2012)
Volume 68, Issue 2, Pages (August 2005)
Volume 88, Issue 6, Pages (December 2015)
Nestin expression in the kidney with an obstructed ureter
Volume 56, Issue 2, Pages (August 1999)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 67, Issue 6, Pages (June 2005)
CD4+ T cells: a potential player in renal fibrosis
TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis  C.Y. Song, B.C. Kim, H.K. Hong,
Volume 76, Issue 8, Pages (October 2009)
Volume 84, Issue 1, Pages (July 2013)
Volume 21, Issue 2, Pages (February 2013)
Volume 88, Issue 6, Pages (December 2015)
Volume 70, Issue 9, Pages (November 2006)
Presentation transcript:

Volume 80, Issue 10, Pages 1035-1044 (November 2011) Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis  Inga Sörensen, Nathan Susnik, Therese Inhester, Jay L. Degen, Anette Melk, Herrmann Haller, Roland Schmitt  Kidney International  Volume 80, Issue 10, Pages 1035-1044 (November 2011) DOI: 10.1038/ki.2011.214 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Fibrinogen accumulates in unilateral ureteral obstruction (UUO) kidneys and fibrinogen deficiency is associated with attenuated tubulointerstitial damage. (a) Immunoblot at 7 days of UUO in wild-type (WT) mice shows a massive increase in renal fibrinogen (Fib) in the obstructed vs contralateral kidney. (b) Fibrinogen immunosignal is confined to the vascular space in contralateral WT kidney, (c) but present throughout the tubulointerstitium after UUO. (d) Representative immunostaining for fibrinogen at 14 days of UUO in Fib+/− showing outer medulla and cortex. (e) Detail from the outer medulla of the same section. (f) As expected, no fibrinogen was found in kidneys from Fib−/− mice. Representative hematoxylin/eosin stains of cortex and outer medulla from Fib+/− and Fib−/− kidneys at (g, h) 7 and (j–m) 14 days of UUO. (i) At day 7, both groups showed dilated tubules with flattened epithelium but no significant difference in tubulointerstitial damage quantification. (i–m) At 14 days, loss of tubular structures and expansion of interstitial mass was significantly more severe in Fib+/− when compared with Fib−/− mice. Original magnifications: × 100 (j, k); × 200 (d); × 400 (b, c, f–h, l, m); × 630 (e). Scale bars represent mean values±s.e.m. *P<0.05; **P<0.01. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Kidney International 2011 80, 1035-1044DOI: (10.1038/ki.2011.214) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Fibrinogen deficiency is associated with reduced collagen accumulation. (a, a’) Representative microphotographs of collagen deposition as visualized by Picrosirius Red staining using (a) light microscopy and (a’) polarized light at 14 days of unilateral ureteral obstruction (UUO). (b) Quantification of Picrosirius Red polarized images in cortex and outer medulla (OM). (c) Immunoblot analysis for Collagen I using Fib+/− and Fib−/− kidneys at 14 days of UUO. (d) Representative microphotographs of immunostaining for CD45. (e) Quantification of CD45-positive leukocytes, CD4-positive lymphocytes, F4/80-positive macrophages, and Ly-6B.2-positive polymorphonuclear cells in UUO kidneys at 7 and/or 14 days of UUO. Original magnification × 400 (a, a’, d). Scale bars represent mean values±s.e.m. *P<0.05; **P<0.01. Kidney International 2011 80, 1035-1044DOI: (10.1038/ki.2011.214) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Fibrinogen deficiency is associated with a reduced upregulation of α-smooth muscle actin (α-SMA) and attenuated fibroblast proliferation. (a) Representative immunostaining for α-SMA, a marker for myofibroblasts, comparing Fib+/− and Fib−/− kidneys at 14 days of unilateral ureteral obstruction (UUO). (b) Immunoblot for α-SMA at 14 days of UUO. (c, d) Representative immuno-double staining for S100A4 and CD45. (c) Higher magnification of boxed area in d showing S100A4-positive/CD45-negative cells (arrows), CD45-positive/S100A4-negative cells (∼), and double-positive cells (asterisks). (e) S100A4-positive/CD45-negative cells were counted as fibroblasts comparing Fib+/− and Fib−/− kidneys at 14 days of UUO. (f, g) Immunostaining for fibroblast marker ER-TR7 and quantification of ER-TR7-positive cells in UUO kidneys at 14 days. Original magnifications: × 400 (a, f); × 630 (c, d). Scale bars represent mean values±s.e.m. *P<0.05. Kidney International 2011 80, 1035-1044DOI: (10.1038/ki.2011.214) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 4 Fibrinogen has a direct effect on the proliferation of interstitial fibroblasts in vivo as well as in vitro. (a) Quantification of immunostaining for Ki67, a cell cycling marker, shows significantly lower rates of interstitial cell proliferation after 7 and 14 days of unilateral ureteral obstruction (UUO) in Fib−/− when compared with Fib+/− kidneys. (b) In vitro 5-bromodeoxyuridine (BrdU) proliferation analysis of rat renal fibroblasts (NRK49-F) after exposure to fibrinogen in different concentrations. (c) In vitro BrdU proliferation analysis of rat renal fibroblasts after exposure to plasma from Fib−/− and Fib+/− mice. (d) Representative laser scanning microphotograph of rat renal fibroblasts immunostained for α-smooth muscle actin (α-SMA; red) and fibronectin (green) after exposure to fibrinogen (1mg/ml) or to transforming growth factor-β (TGF-β; 2ng/ml; positive control). Fibrinogen did not significantly induce α-SMA or fibronectin expression. Original magnification (d) × 630. Scale bars represent mean values±s.e.m. *P<0.05; **P<0.01; ***P<0.0001. Kidney International 2011 80, 1035-1044DOI: (10.1038/ki.2011.214) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 5 Mitogenic effect of fibrinogen on renal fibroblasts is mediated via Toll-like receptor (TLR)2, TLR4, and intercellular adhesion molecule 1 (ICAM-1). (a) 5-Bromodeoxyuridine (BrdU) proliferation assay in rat renal fibroblasts induced by fibrinogen after TLR2, TLR4, or MyD88 small interfering RNA (siRNA) knockdown (b). (c) BrdU proliferation of primary renal fibroblasts from wild-type (WT) and MyD88 knockout mice after exposure to fibrinogen. (d) BrdU proliferation in the presence of blocking antibodies to ICAM-1 (ICAM-1 Ab) after fibrinogen induction. (e) BrdU proliferation induced by fibrinogen after siRNA knockdown of ICAM-1. Effects of TLR2, TLR4, and ICAM-1 are additive (e). Fibrinogen concentration in all assays 1mg/ml. Scale bars represent mean values±s.e.m. *P<0.05; **P<0.01. Kidney International 2011 80, 1035-1044DOI: (10.1038/ki.2011.214) Copyright © 2011 International Society of Nephrology Terms and Conditions